225 related articles for article (PubMed ID: 12723544)
1. [Off-label prescriptions. Drug use outside of established guidelines and treatment standard].
Weissbach L; Boedefeld EA
Urologe A; 2003 Mar; 42(3):428-32. PubMed ID: 12723544
[No Abstract] [Full Text] [Related]
2. [Prescription of drugs without registered indication].
Wetterling T
Fortschr Neurol Psychiatr; 2004 May; 72(5):245-54. PubMed ID: 15136945
[TBL] [Abstract][Full Text] [Related]
3. [Negative lists and positive lists--health policy aspects].
Huber E
Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):624-7. PubMed ID: 9527455
[TBL] [Abstract][Full Text] [Related]
4. [Prerequisites in prescribing practice: physician decision processes].
Dierks C
Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):620-4. PubMed ID: 9527454
[TBL] [Abstract][Full Text] [Related]
5. [Increased legal liability in off-label use].
Broglie M
Aktuelle Urol; 2006 Nov; 37(6):417-9. PubMed ID: 17153265
[No Abstract] [Full Text] [Related]
6. [Legal boundaries of negative and positive lists].
Arndt M
Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):630-2. PubMed ID: 9527457
[TBL] [Abstract][Full Text] [Related]
7. [Clinical trials and studies of the German Society for Paediatric Oncology and Haematology (GPOH) and the European Directive for the Implementation of Good Clinical Practice in the Conduct of Clinical Trials].
Graf N; Göbel U
Klin Padiatr; 2004; 216(3):129-31. PubMed ID: 15175956
[No Abstract] [Full Text] [Related]
8. [Off-label use in psychopharmacotherapy. Letter to Federal Minister Ulla Schmidt, Pulheim, 22 January 2003].
Fritze J
Nervenarzt; 2003 Apr; 74(4):389; discussion 390. PubMed ID: 12800838
[No Abstract] [Full Text] [Related]
9. [Limited prescribing freedom by federal cost regulation?].
Lasek R
Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):633-5. PubMed ID: 9527458
[TBL] [Abstract][Full Text] [Related]
10. [DMP recommends only 4 antidiabetic drugs. When may different prescriptions be allowed?].
MMW Fortschr Med; 2003 Sep; 145(38):62. PubMed ID: 14603690
[No Abstract] [Full Text] [Related]
11. [A concept for a clearing procedure for guidelines in Germany].
Lauterbach KW; Lubecki P; Oesingmann U; Ollenschläger G; Richard S; Straub C
Z Arztl Fortbild Qualitatssich; 1997 Jun; 91(3):283-8. PubMed ID: 9312434
[TBL] [Abstract][Full Text] [Related]
12. [Development of guidelines in health care facilities].
Eversmann BJ
Z Arztl Fortbild Qualitatssich; 1997 Aug; 91(5):479-81. PubMed ID: 9377704
[No Abstract] [Full Text] [Related]
13. [Pioglitazone in evaluation by IQWiG (Institute for Quality and Cost Effectiveness in Public Health)--tunnel vision instead of broad view].
MMW Fortschr Med; 2008 Aug; 150(32-35):56-7. PubMed ID: 19009700
[No Abstract] [Full Text] [Related]
14. [Guidelines as the principle of rational medical management].
Bauer H
Chirurg; 1998 Feb; 69(2):suppl 33-8. PubMed ID: 9551264
[No Abstract] [Full Text] [Related]
15. [Practice parameters, guidelines, standard].
Ratzel R
Chirurg; 2000 Feb; 71(2):suppl 29-33. PubMed ID: 10734598
[No Abstract] [Full Text] [Related]
16. [Solutions for off-label therapy].
Schmidt WA
Z Rheumatol; 2003; 62(Suppl 2):II54-6. PubMed ID: 14648094
[TBL] [Abstract][Full Text] [Related]
17. [Guidelines in surgery: from the viewpoint of the legal process].
Ulsenheimer K
Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():74-8. PubMed ID: 9574101
[No Abstract] [Full Text] [Related]
18. [Guidelines for quality assessment in psychiatric clinics].
Weig W
Nervenarzt; 1996 Nov; 67(11):973-4. PubMed ID: 9064561
[No Abstract] [Full Text] [Related]
19. [The 12th German Drug Law (AMG) amendment: an obstruction for non-commercial clinical trials?].
Schwarz S; Frölich L; Striebel JP; Hennerici MG
Dtsch Med Wochenschr; 2007 Jan; 132(3):108-12. PubMed ID: 17219346
[No Abstract] [Full Text] [Related]
20. [Guidelines for quality assessment in psychiatric clinics. A brief introduction].
Kunze H
Nervenarzt; 1996 Nov; 67(11):970-1. PubMed ID: 9064559
[No Abstract] [Full Text] [Related]
[Next] [New Search]
